Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
68Ga-DOTA-Bombesin PET/MRI in Prostate Cancer
NCT02440308Phase 2Completed
- Sponsor
- Stanford University
- Start
- Apr 2015
- Primary completion
- Jun 2015
- Countries
- 1
01
Overview
A Phase 2 trial of 68Ga-DOTA-Bombesin in prostate cancer (PCa), sponsored by Stanford University. Started Apr 2015; status: completed.
02
Drugs
68Ga-DOTA-Bombesin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02440308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02440308.